First-pass extracted concept

Parkinson's syndrome

Candidate: concept label1 source documents5 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

Instead, each affected individual develops a virtually unique form of Parkinson's syndrome.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2022Annual Review of Pathology Mechanisms of DiseaseDOI PubMed

1 evidence snippet 5 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1disease heterogeneitysupports2022Source 1DOI PubMed

Parkinson's disease is clinically, pathologically, and genetically heterogeneous rather than a single cohesive disorder.

Claim 2genetic architecturesupports2022Source 1DOI PubMed

Nearly all Parkinson's disease is genetically influenced, with more than 100 genes or genetic loci identified and most cases likely arising from interactions among many common and rare variants.

Claim 3mechanistic convergencesupports2022Source 1DOI PubMed

Experimental genetic dissection of Parkinson's syndrome converges on synaptic, lysosomal, mitochondrial, and immune-mediated mechanisms of pathogenesis.

Claim 4pathology patternsupports2022Source 1DOI PubMed

Parkinson's disease is most commonly characterized by alpha-synuclein protein pathology, but the distribution varies and other pathologies can modify or mimic manifestations.

Claim 5translational outlooksupports2022Source 1DOI PubMed

Advances in mechanistic understanding, biomarkers, and targeted therapies suggest that precision medicine strategies for Parkinson's syndrome may become successful.